Lung Cancer Clinical Trial

Clinical Trial Finder Lung Cancer Trials

A Phase I Study of Cetuximab in Combination With Gefitinib in Patients With Advanced/Metastatic Non-Small Cell Lung Cancer

See Locations Near You

Summary

The purpose of this study is to find a safe and effective dose of Erbitux and Iressa for subject with non small cell lung cancer.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Subjects with advanced or metastatic non small cell lung cancer.
Subjects should have had at least one prior chemotherapy with a platinum based therapy.

Exclusion Criteria:

Subjects are excluded from this study if they do not have non small cell lung cancer that is advanced or metastatic or have not had at least one prior platinum based chemotherapy.

Study is for people with:

Lung Cancer

Phase:

Phase 1

Estimated Enrollment:

30

Study ID:

NCT00162318

Recruitment Status:

Completed

Sponsor:

Eli Lilly and Company

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Local Institution
Pittsburgh Pennsylvania, , United States

How clear is this clinincal trial information?

Study is for people with:

Lung Cancer

Phase:

Phase 1

Estimated Enrollment:

30

Study ID:

NCT00162318

Recruitment Status:

Completed

Sponsor:


Eli Lilly and Company

How clear is this clinincal trial information?

Clinical Trial Resources

Why I’d Choose a Clinical Trial For Myself
Clinical Trials Can be Life-Saving for Some
When Should I Consider Clinical Trials?
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider